跳至主要内容
临床试验/ACTRN12616000016437
ACTRN12616000016437终止4 期

Pregabalin for the management of post-dural puncture headache after unintentional dural puncture in obstetric patients: a randomised, double-blind, placebo-controlled trial

King Edward Memorial Hospital for Women0 个研究点目标入组 300 人开始时间: 2016年1月13日最近更新:

试验速览

阶段
4 期
状态
终止
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1.Obstetric women aged 18 years and over
  • 2.An unintentional dural puncture at the time of epidural analgesia for labour and delivery, confirmed by observation of efflux of cerebrospinal fluid from the needle or catheter; by identification of CSF from an epidural catheter; or by positive test-dosing for subarachnoid placement.

排除标准

  • 1.Attempted postpartum prevention of PDPH using any therapy other than intrathecal epidural catheter placement, including prophylactic epidural blood patch.
  • 2.Onset of PDPH prior to study drug administration
  • 3.Renal impairment
  • 4.Contraindication to use or exposure to pregabalin within past 72 hours
  • 5.ASA 4 status
  • 6.Women planning to breastfeed a premature baby
  • 7.Concurrent administration of drugs that may possibly impact on the severity of PDPH, namely oral tablets of or intravenous caffeine, triptans, hydrocortisone, oral theophylline or intravenous aminophylline, epidural morphine.

研究者

发起方
King Edward Memorial Hospital for Women

相似试验